Your browser doesn't support javascript.
loading
Ocular tropism of SARS-CoV-2 in animal models with retinal inflammation via neuronal invasion following intranasal inoculation.
Jeong, Gi Uk; Kwon, Hyung-Jun; Ng, Wern Hann; Liu, Xiang; Moon, Hyun Woo; Yoon, Gun Young; Shin, Hye Jin; Lee, In-Chul; Ling, Zheng Lung; Spiteri, Alanna G; King, Nicholas J C; Taylor, Adam; Chae, Ji Soo; Kim, Chonsaeng; Ahn, Dae-Gyun; Kim, Kyun-Do; Ryu, Young Bae; Kim, Seong-Jun; Mahalingam, Suresh; Kwon, Young-Chan.
Afiliação
  • Jeong GU; Department of Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon, 34114, Republic of Korea.
  • Kwon HJ; Department of Functional Biomaterial Research Center, Korea Research Institute of Bioscience and Biotechnology, Jeongeup, 56212, Republic of Korea.
  • Ng WH; Center for Companion Animal New Drug Development, Jeonbuk Branch, Korea Institute of Toxicology, Jeongeup, 53212, Republic of Korea.
  • Liu X; Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Gold Coast, QLD, Australia.
  • Moon HW; Global Virus Network (GVN) Centre of Excellence in Arboviruses, Griffith University, Gold Coast, QLD, Australia.
  • Yoon GY; School of Pharmacy and Medical Sciences, Griffith University, Gold Coast, QLD, Australia.
  • Shin HJ; Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Gold Coast, QLD, Australia.
  • Lee IC; Global Virus Network (GVN) Centre of Excellence in Arboviruses, Griffith University, Gold Coast, QLD, Australia.
  • Ling ZL; School of Pharmacy and Medical Sciences, Griffith University, Gold Coast, QLD, Australia.
  • Spiteri AG; Department of Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon, 34114, Republic of Korea.
  • King NJC; Department of Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon, 34114, Republic of Korea.
  • Taylor A; Department of Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon, 34114, Republic of Korea.
  • Chae JS; Department of Microbiology, Chungnam National University School of Medicine, Daejeon, 35015, Republic of Korea.
  • Kim C; Department of Functional Biomaterial Research Center, Korea Research Institute of Bioscience and Biotechnology, Jeongeup, 56212, Republic of Korea.
  • Ahn DG; Center for Companion Animal New Drug Development, Jeonbuk Branch, Korea Institute of Toxicology, Jeongeup, 53212, Republic of Korea.
  • Kim KD; Viral Immunopathology Laboratory, The Charles Perkins Centre, The University of Sydney, Sydney, NSW, 2006, Australia.
  • Ryu YB; School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2006, Australia.
  • Kim SJ; Viral Immunopathology Laboratory, The Charles Perkins Centre, The University of Sydney, Sydney, NSW, 2006, Australia.
  • Mahalingam S; School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2006, Australia.
  • Kwon YC; Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Gold Coast, QLD, Australia.
Nat Commun ; 13(1): 7675, 2022 12 12.
Article em En | MEDLINE | ID: mdl-36509737
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article